Literature DB >> 10400739

Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.

S Fais1, C Lapenta, S M Santini, M Spada, S Parlato, M Logozzi, P Rizza, F Belardelli.   

Abstract

In a previous study, we had found that the extent of T-cell dysfunctions induced by a T-tropic strain of human immunodeficiency virus type 1 (HIV-1) in SCID mice reconstituted with human peripheral blood lymphocytes (hu-PBLs) (hu-PBL-SCID mice) was related to the in vivo state of activation of the human lymphocytes. In this article, we compared the effect of infection of hu-PBL-SCID mice with either T-tropic (X4) or M-tropic (R5) strains of HIV-1 by performing virus inoculation at either 2 h or 2 weeks after the hu-PBL transfer, when the human T cells exhibited a marked activation state or a predominant memory phenotype, respectively. A comparable level of infection was found when hu-PBL-SCID mice were challenged with either the SF162 R5 or the IIIB X4 strain of HIV at 2 h postreconstitution, while at 2 weeks, the R5 virus infection resulted in a higher level of HIV replication than the X4 virus. The R5 strain induced a marked human CD4(+) T-cell depletion along with a drop in levels of human immunoglobulin M in serum and release of soluble factors at both infection times, while the X4 virus induced severe immune dysfunctions only at 2 h. Of interest, injection of hu-PBLs into SCID mice resulted in a marked up-regulation of CCR5 on human CD4(+) T cells. The percentage of CXCR4(+) cells did not change after transplantation, even though a significant decrease in antigen expression was observed. Comparative experiments with two molecular clones of HIV-1 (X4 SF2 and R5 SF162) and two envelope recombinant viruses generated from these viruses showed that R5 viruses (SF162 and the chimeric env-SF162-SF2) caused an extensive depletion of human CD4(+) T cells in SCID mice at both 2 h and 2 weeks after reconstitution, while the X4 viruses (SF2 and the chimeric env-SF2-SF162) induced CD4 T-cell depletion only when infection was performed at the 2-h reconstitution time. These results emphasize the importance of the state of activation/differentiation of human CD4(+) T cells and gp120-coreceptor interactions at the time of primary infection in determining HIV-1 pathogenicity in the hu-PBL-SCID mouse model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400739      PMCID: PMC112726     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

Review 2.  Mechanisms of lymphocyte killing by HIV.

Authors:  C R Casella; T H Finkel
Journal:  Curr Opin Hematol       Date:  1997-01       Impact factor: 3.284

3.  The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Authors:  G R Picchio; R J Gulizia; K Wehrly; B Chesebro; D E Mosier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 4.  Co-receptors for HIV-1 entry.

Authors:  J P Moore; A Trkola; T Dragic
Journal:  Curr Opin Immunol       Date:  1997-08       Impact factor: 7.486

5.  Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection.

Authors:  T C Quinn; P Piot; J B McCormick; F M Feinsod; H Taelman; B Kapita; W Stevens; A S Fauci
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

6.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  Human immunodeficiency virus infection of human-PBL-SCID mice.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson; D H Spector; S A Spector
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

8.  Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice.

Authors:  S M Krams; K Dorshkind; M E Gershwin
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.

Authors:  M Tary-Lehmann; A Saxon
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  19 in total

1.  Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Authors:  G M Bahr; E C Darcissac; N Castéran; C Amiel; C Cocude; M J Truong; J Dewulf; A Capron; Y Mouton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome.

Authors:  Ghalib Alkhatib
Journal:  Stem Cells Dev       Date:  2009 Jan-Feb       Impact factor: 3.272

3.  Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

Authors:  Jasminka Sterjovski; Michael Roche; Melissa J Churchill; Anne Ellett; William Farrugia; Lachlan R Gray; Daniel Cowley; Pantelis Poumbourios; Benhur Lee; Steven L Wesselingh; Anthony L Cunningham; Paul A Ramsland; Paul R Gorry
Journal:  Virology       Date:  2010-06-08       Impact factor: 3.616

5.  RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.

Authors:  Sang-Soo Kim; Dan Peer; Priti Kumar; Sandesh Subramanya; Huaquan Wu; Deshratan Asthana; Katsuyoshi Habiro; Yong-Guang Yang; N Manjunath; Motomu Shimaoka; Premlata Shankar
Journal:  Mol Ther       Date:  2009-12-08       Impact factor: 11.454

6.  Human immunodeficiency virus persistence and production in T-cell development.

Authors:  Kevin B Gurney; Christel H Uittenbogaart
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

7.  Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.

Authors:  Santhi Gorantla; Kathlyn Santos; Vakara Meyer; Stephen Dewhurst; William J Bowers; Howard J Federoff; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Authors:  Priti Kumar; Hong-Seok Ban; Sang-Soo Kim; Haoquan Wu; Todd Pearson; Dale L Greiner; Amale Laouar; Jiahong Yao; Viraga Haridas; Katsuyoshi Habiro; Yong-Guang Yang; Ji-Hoon Jeong; Kuen-Yong Lee; Yong-Hee Kim; Sung Wan Kim; Matthias Peipp; Georg H Fey; N Manjunath; Leonard D Shultz; Sang-Kyung Lee; Premlata Shankar
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

9.  Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants.

Authors:  Livia Pedroza-Martins; W John Boscardin; Deborah J Anisman-Posner; Dominique Schols; Yvonne J Bryson; Christel H Uittenbogaart
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis.

Authors:  Satoru Watanabe; Shinrai Ohta; Misako Yajima; Kazuo Terashima; Mamoru Ito; Hideo Mugishima; Shigeyoshi Fujiwara; Kazufumi Shimizu; Mitsuo Honda; Norio Shimizu; Naoki Yamamoto
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.